Laos XP

Lao XP is a pharmaceutical manufacturing company based in Vientiane, Laos, specializing in the production of high-quality generic medications. The company gained significant international recognition for its rapid production of generic oral antivirals during the COVID-19 pandemic, including versions of molnupiravir and nirmatrelvir/ritonavir. Beyond infectious diseases, Lao XP focuses on oncology, producing generic versions of targeted therapies for non-small cell lung cancer and prostate cancer. By operating in Laos, the company utilizes international trade flexibilities to provide affordable access to essential medicines in developing regions. Their facilities are designed to meet international manufacturing standards to ensure the safety and efficacy of their generic portfolio.